Summary
Lung transplantation is an established therapeutic option for cystic fibrosis patients with advanced lung disease, and the criteria for when a patient should be considered for lung transplantation have been quite stable for the last 10 years. Several contraindications have to be considered on an individual basis. The decision for lung transplantation is a highly individual one and the operation requires psychosocial and medical preparation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsLiteratur
Kerem E, Reisman J, Corey M (1992) Prediction of Mortality in Patients with Cystic Fibrosis. N Engl J Med 326: 1187 – 1191
Mallory G. (1996) Persönliche Mitteilung. Cystic Fibrosis World Conference, Orlando
Webb AK, Egan JJ, Dodd ME. (1996) Clinical Management of Cystic Fibrosis Patients Awaiting and Immediately Following Lung Transplantation. In: Dodge JA, Brock DJH, Widdicombe JH (eds) Cystic Fibrosis-Current Topics, Volume 3, London 1996
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Paul, K. (1997). Kriterien zur Vormerkung zur Lungentransplantation bei Mukoviszidose. In: Paditz, E. (eds) Nasale Maskenbeatmung im Kindes- und Erwachsenenalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60853-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-60853-7_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-63154-5
Online ISBN: 978-3-642-60853-7
eBook Packages: Springer Book Archive